摘要
目的分析导流杂交HPV检测联合TCT检测在宫颈癌筛查中的应用价值。方法选取于我院就诊疑似宫颈病变的84例女性患者,均行导流杂交HPV、TCT及阴道镜下宫颈活组织检测。以阴道镜下宫颈活组织检测结果为金标准,分析导流杂交HPV和TCT检测以及二者联合检测的结果与效能。结果阴道镜下宫颈活组织检测阳性率为33.33%,导流杂交HPV、TCT及二者联合检测阳性率分别为27.38%、26.19%和32.14%。二者联合检测的灵敏度高于导流杂交HPV与TCT单一检测(P<0.05);二者联合检测的约登指数高于单一方法检测。结论导流杂交HPV联合TCT检测能够准确地筛查诊断宫颈癌及癌前病变,其灵敏度较高。
Objective To analyze the application value of HybriMax HPV detection combined with TCT detection in cervical cancer screening.Methods A total of 84 female patients with suspected cervical lesions treated in our hospital were selected and detected by HybriMax HPV,TCT and cervical biopsy under colposcope.The results of cervical biopsy under colposcope seted as the gold standard,the results and efficiency of HybriMax HPV,TCT and their combination detection were analyzed.Results The positive rates of cervical biopsy under colposcope was 33.33%,and the positive rates of HybriMax HPV,TCT and the combination detection were 27.38%,26.19%and 32.14%respectively.The sensitivity of the combination detection were higher than that in the detection of HybriMax HPV and TCT single(P<0.05);the Youden index of the combined detection of the two methods was higher than that of the single method.Conclusion HybriMax HPV combined with TCT detection can accurately screen and diagnose cervical cancer and precancerous lesions,with higher sensitivity.
作者
苏军侠
韩秀红
SU Jun-xia;HAN Xiu-hong(Chengcheng County Maternal and Child Health Care Hospital,Weinan 715200;the Second Hospital of Chinese Medicine of Baojo City,Baoji 721300,China)
出处
《临床医学研究与实践》
2020年第7期91-92,共2页
Clinical Research and Practice
